🗓️ Date: February 11, 2026
🕔 Time: 17:00 - 19:30
📍 Location: Forskningsparken / Oslo Science Park - Forum Auditorium
🎟️ Tickets: Free for WiLD Norway and/or TLSC members, NOK 250 non-refundable fee for non-members. Sign-up required!

WiLD Norway and The Life Science Cluster invite you to an in-depth evening exploring why GLP-1 biology matters specifically for women, and why it deserves far more attention in research, clinical practice, and leadership conversations.

GLP-1 is often discussed in the context of diabetes & weight management. However, it also plays a critical role in inflammation, cardiometabolic disease, MAFLD/MASH, neuroinflammation, and immunology. These mechanisms have clear and underexplored implications for women’s health across the life course - and the impact of this drug might very well be different for women that we once anticipated.

This event brings science to the forefront, connecting biological insight with broader questions of equity, representation, and decision-making in life sciences.

Jens Juul Holst

Jens Juul Holst is a renowned Danish physician and physiologist whose discoveries have fundamentally transformed the treatment of diabetes and obesity. Born in 1945, he is best known for discovering glucagon-like peptide-1 (GLP-1), a gut hormone that plays a central role in regulating blood sugar and appetite and underpins breakthrough therapies such as Ozempic and Wegovy.

A Professor of Medical Physiology at the University of Copenhagen and former Scientific Director of the Novo Nordisk Foundation Center for Basic Metabolic Research, Holst has led pioneering research into gut hormones and incretin biology since the 1980s. His work revealed GLP-1’s dual role in stimulating insulin secretion and promoting satiety, reshaping understanding of metabolic regulation and informing modern approaches to obesity, diabetes, and bariatric surgery.

With an H-index of 166 (WoS, August 2025), he is among the most cited European scientists in his field. He has authored more than 1900 publications (about 1802 listed in PubMed) that have received more than 119,061 citations in Web of Science as of August 2025. According to PubMed he has 105 new titles in 2024 and 2025.

Format & Agenda

  • Welcome and introduction to WiLD Norway

  • Keynote by Prof. Jens Juul Holst

  • Open Q&A

  • Networking and informal discussion

Please Register Below